340B Drug Pricing Program

Nevada Shelves Program Cuts in Victory for HIV Patients: Federal 340B Changes Forestalled

Thursday, January 14, 2021 - 12:36am

This delay will allow DPBH additional time to review the impact of community partners using the federal 340B program and the program income received directly to them and the impact of rebate revenue received at NMAP.

Key Points: 
  • This delay will allow DPBH additional time to review the impact of community partners using the federal 340B program and the program income received directly to them and the impact of rebate revenue received at NMAP.
  • After Nevada health officials first announced the plan, many community partners and nonprofit HIV providers decried the states action, warning it could have a profound and negative impact on patient care.
  • The 340B program, which costs taxpayers nothing, allows Ryan White HIV Clinics and providers to acquire HIV drugs at a steep discount, using the savings from those discounts to pay for HIV services not covered by their Ryan White grants.
  • Some of the advocates and HIV providers also ran an advocacy ad ( 340B ad ) targeting Nevada health officials and legislators urging state officials to not to interfere with the states successful 340B program.

AHF to Protest Amgen Over Unlawful Drug Restrictions

Monday, December 21, 2020 - 11:59pm

They depend on the savings from the 340B program to keep open to stretch existing federally funded health care programs.

Key Points: 
  • They depend on the savings from the 340B program to keep open to stretch existing federally funded health care programs.
  • The rapacious greed of Amgen is limitless, said John Hassell, national director of advocacy for AHF.
  • AHF calls on the U.S. Department of Health and Human Services ( HHS ) to do its job and stop this callous drug industry attack on the U.S. healthcare safety net.
  • Its a social justice imperative for the new administration to protect the 340B Drug Discount Program.

AHF to HRSA: Reject Kalderos’ Plan to Hurt 340B Drug Discount Program

Monday, December 21, 2020 - 9:45pm

The Kalderos plan would convert the 340B Drug Price Program from a discount to a rebate program and would set Kalderos up as the arbiter of who will get the rebate and when, putting the fox in charge of the henhouse, said Tom Myers, AHF chief of public affairs and general counsel.

Key Points: 
  • The Kalderos plan would convert the 340B Drug Price Program from a discount to a rebate program and would set Kalderos up as the arbiter of who will get the rebate and when, putting the fox in charge of the henhouse, said Tom Myers, AHF chief of public affairs and general counsel.
  • Under the 340B statute, drug manufacturers are required to sell drugs to safety net providers at or below the discount price.
  • Congress intentionally expanded the 340B program with the full knowledge and explicit approval of the drug industry.
  • AHF urges the U.S. Health Resources and Services Administration which runs the 340B to assert its authority as enforcer of the 340B program and reject the Kalderos steal, concluded Myers.

Kalderos upgrades 340B Pay platform, giving covered entities more options

Tuesday, December 15, 2020 - 10:15pm

CHICAGO, Dec. 15, 2020 /PRNewswire/ -- Drug Discount Management company Kalderos today announced a significant upgrade to its 340B Pay solution that gives covered entities more choice in how they realize the benefits of the 340B program.

Key Points: 
  • CHICAGO, Dec. 15, 2020 /PRNewswire/ -- Drug Discount Management company Kalderos today announced a significant upgrade to its 340B Pay solution that gives covered entities more choice in how they realize the benefits of the 340B program.
  • The solution enables manufacturers, covered entities and Medicaid agencies to work together to effectuate 340B discounts compliantly and efficiently.
  • 340B Pay, and its tools, Request and Verify, allow providers of any size to request 340B rebates and manufacturers to verify and pay them through a third party payment partner.
  • With 340B rebate funds from contract pharmacy dispenses flowing directly to covered entities, covered entities will benefit from greater control over program savings, enabling them to better serve patients.

28 State AGs Demand HHS Sec. Azar Enforce Laws on 340B Drug Pricing

Tuesday, December 15, 2020 - 1:27am

AIDS Healthcare Foundation ( AHF ) praised 28 U.S. state attorneys general who have drawn a line in the sand to protect an essential part of the healthcare safety net: the 340B Drug Pricing Program against the limitless greed of the drug industry.

Key Points: 
  • AIDS Healthcare Foundation ( AHF ) praised 28 U.S. state attorneys general who have drawn a line in the sand to protect an essential part of the healthcare safety net: the 340B Drug Pricing Program against the limitless greed of the drug industry.
  • In their December 14 letter , the bipartisan group of elected attorneys general demand that U.S. Health and Human Services ( HHS ) Secretary Alex Azar take immediate steps to enforce the law to address drug companies unlawful refusal to provide critical drug discounts to covered entities such as community health centers under the 340B Drug Pricing Program.
  • View the full release here: https://www.businesswire.com/news/home/20201214005885/en/
    Letter to HHS Secretary Alex Azar from 28 state AGs demanding that he enforce the law on 340B drug pricing as required by section 340B of the U.S. Health Services Act.
  • AHF has repeatedly criticized these nine drug companies whose actions the AGs are calling unlawful.

AHF Blasts Amgen Over Drug Restrictions; Asks Biden Administration to Sanction It and Others

Thursday, December 10, 2020 - 10:49pm

The U.S. government already gives special favors to drug companies to produce expensive orphaned drugs for rare diseases that would otherwise be unaffordable.

Key Points: 
  • The U.S. government already gives special favors to drug companies to produce expensive orphaned drugs for rare diseases that would otherwise be unaffordable.
  • They depend on the savings from the 340B program to keep open to stretch existing federally funded health care programs.
  • Its a social justice imperative for the new administration to protect the 340B Drug Discount Program.
  • To learn more about AHF, please visit our website: www.aidshealth.org , find us on Facebook: www.facebook.com/aidshealth and follow us @aidshealthcare .

Alliance of Community Health Centers Sues State to Preserve Benefits of the Federal 340B Drug Pricing Program

Thursday, October 29, 2020 - 4:39pm

SACRAMENTO, Calif., Oct. 29, 2020 /PRNewswire/ -- The Community Health Center Alliance for Patient Access (CHCAPA) has filed suit in federal court contesting the state's plan to 'carve out' the pharmacy benefit from Medicaid managed care, thus preventing community health centers from benefiting from the Federal 340B Drug Pricing Program.

Key Points: 
  • SACRAMENTO, Calif., Oct. 29, 2020 /PRNewswire/ -- The Community Health Center Alliance for Patient Access (CHCAPA) has filed suit in federal court contesting the state's plan to 'carve out' the pharmacy benefit from Medicaid managed care, thus preventing community health centers from benefiting from the Federal 340B Drug Pricing Program.
  • "The state's ill-conceived action threatens the ability of many community health centers to provide critical programs to uninsured and low-income families across the state," said Anthony White, President of the CHCAPA, a statewide organization of federally qualified health centers, serving 2.1 million patients.
  • "Medi-Cal patients depend on us for access to comprehensive primary and preventive health care," said Leslie Abasta-Cummings, CEO of Livingston Community Health, which operates six health centers in the Central Valley.
  • "Excluding our centers from the 340B Program will jeopardize patients' access to care, increase risk for health problems and raise costs," said Ronald E. Castle, CEO at Community Health Centers of the Central Coast, Inc., where he oversees 30 health centers and seven mobile dental and medical units.

Sentry stands with Ryan White Clinics as study highlights importance of funding and 340B program in managing HIV/AIDS epidemic

Monday, October 26, 2020 - 11:57am

"Sentry is proud to support Ryan White Clinics for 340B Access and its members through advocacy, technology and the expertise they need to maximize their 340B benefits and continue providing high-quality care to their patients."

Key Points: 
  • "Sentry is proud to support Ryan White Clinics for 340B Access and its members through advocacy, technology and the expertise they need to maximize their 340B benefits and continue providing high-quality care to their patients."
  • Ryan White providers are also eligible for the federal 340B Drug Discount Program and use it to expand affordable access to expensive and life-saving HIV/AIDS medications.
  • It examines access to HIV care and the important roles of the Ryan White HIV/AIDS Program and the 340B program for their clients and for viral suppression.
  • It also discusses policies related to Ryan White program income for clinic grantees and funding sources.

Progressive Care to Expand 340B Third Party Administrator Services Nationwide

Thursday, October 22, 2020 - 12:00pm

Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.

Key Points: 
  • Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
  • Such forward-looking statements reflect the Companys expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties.
  • These statements include but are not limited to statements regarding our planned expansion of ClearMetrX 340B third party administration services nationwide and future demand for our services.
  • When used herein, the words anticipate, believe, estimate, upcoming, plan, target, intend and expect and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements.

NACHC Files Suit Against HHS To Defend The 340B Drug Discount Program From Rx Manufacturer Attacks

Wednesday, October 21, 2020 - 3:36pm

BETHESDA, Md., Oct. 21, 2020 /PRNewswire/ -- The National Association of Community Health Centers (NACHC) has filed suit to take action in response to recent moves by drug manufacturers to dismantle the health center federal 340B drug discount program.

Key Points: 
  • BETHESDA, Md., Oct. 21, 2020 /PRNewswire/ -- The National Association of Community Health Centers (NACHC) has filed suit to take action in response to recent moves by drug manufacturers to dismantle the health center federal 340B drug discount program.
  • The 340B program is critical for health centers' ability to make medications affordable for patients, and to generate savings that are used to expand access to other services.
  • NACHC estimates that 10 million low-income patients will suffer reduced access to health center services and affordable medicine unless HHS acts now to protect the program.
  • NACHC's suit presses HHS to promulgate administrative dispute resolution ("ADR") regulations and implement a process to adjudicate and remedy the 340B violations.